BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37318608)

  • 1. Challenges in Accurate Diagnosis of HCC in FALD: A Case Series.
    Feeley M; Hopkins K; Grinspan LT; Schiano T; Love B; Chan A; Lewis S; Zaidi AN
    Pediatr Cardiol; 2023 Oct; 44(7):1447-1453. PubMed ID: 37318608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fontan-associated liver disease: A review.
    Gordon-Walker TT; Bove K; Veldtman G
    J Cardiol; 2019 Sep; 74(3):223-232. PubMed ID: 30928109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fontan-associated liver disease and hepatocellular carcinoma in adults.
    Kogiso T; Tokushige K
    Sci Rep; 2020 Dec; 10(1):21742. PubMed ID: 33303924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure - A Nationwide Survey in Japan.
    Kuwabara M; Niwa K; Toyoda T; Shirai T; Tateno S; Ohuchi H; Tanaka Y; Ichida F; Fujisawa T; Akagi T; Mori Y;
    Circ J; 2018 Mar; 82(4):1155-1160. PubMed ID: 29445059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes.
    Possner M; Gordon-Walker T; Egbe AC; Poterucha JT; Warnes CA; Connolly HM; Ginde S; Clift P; Kogon B; Book WM; Walker N; Wagenaar LJ; Moe T; Oechslin E; Kay WA; Norris M; Dillman JR; Trout AT; Anwar N; Hoskoppal A; Broering DC; Bzeizi K; Veldtman G
    Int J Cardiol; 2021 Jan; 322():142-148. PubMed ID: 32828959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hepatocellular carcinoma during Fontan-associated liver disease follow-up: a report of three cases.
    Onishi H; Toh N; Akagi T; Baba K; Kotani Y; Takaki A; Kasahara S; Ito H
    Clin J Gastroenterol; 2024 Feb; 17(1):148-154. PubMed ID: 38032452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of liver cirrhosis and hepatocellular carcinoma among perioperative survivors of the Fontan operation.
    Inuzuka R; Nii M; Inai K; Shimada E; Shinohara T; Kogiso T; Ono H; Otsuki SI; Kurita Y; Takeda A; Hirono K; Takei K; Yasukohchi S; Yoshikawa T; Furutani Y; Shinozaki T; Matsuyama Y; Senzaki H; Tokushige K; Nakanishi T
    Heart; 2023 Jan; 109(4):276-282. PubMed ID: 35768191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.
    Téllez L; Rodríguez de Santiago E; Minguez B; Payance A; Clemente A; Baiges A; Morales-Arraez D; La Mura V; Llop E; Garrido E; Garrido-Lestache E; Tasayco S; Bruno O; Prieto R; Montserrat S; Pons M; Olavarría A; Dos L; Legendre A; Jesús Del Cerro M; Bañares R; García-Pagán JC; Rautou PE; Albillos A;
    J Hepatol; 2020 Apr; 72(4):702-710. PubMed ID: 31726116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fontan-associated liver disease current status and transplantation consideration].
    Liu X; Tu JZC; Teng Y; Chen JM
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):109-112. PubMed ID: 36948859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease.
    Sagawa T; Kogiso T; Sugiyama H; Hashimoto E; Yamamoto M; Tokushige K
    Hepatol Res; 2020 Jul; 50(7):853-862. PubMed ID: 32219953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust Effect of Hepatic Arterial Infusion Chemotherapy and Radiation Therapy on Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease.
    Suzuki H; Niizeki T; Shirono T; Koteda Y; Kinjyo Y; Mizukami N; Koda M; Ota S; Nakano M; Okamura S; Iwamoto H; Shimose S; Noda Y; Kamachi N; Kajiwara A; Suda K; Akiba J; Yano H; Kuromatsu R; Koga H; Torimura T
    Intern Med; 2022 Apr; 61(8):1145-1150. PubMed ID: 34565776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of Fontan-Associated Liver Disease.
    Brown MJ; Kolbe AB; Hull NC; Hilscher M; Kamath PS; Yalon M; Gu CN; Amawi ADT; Venkatesh SK; Wells ML
    J Comput Assist Tomogr; 2024 Jan-Feb 01; 48(1):1-11. PubMed ID: 37574655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of Fontan-Associated Liver Disease Correlates with Fontan Hemodynamics.
    Schleiger A; Salzmann M; Kramer P; Danne F; Schubert S; Bassir C; Müller T; Müller HP; Berger F; Ovroutski S
    Pediatr Cardiol; 2020 Apr; 41(4):736-746. PubMed ID: 32006084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive ultrasound technique for assessment of liver fibrosis and cardiac function in Fontan-associated liver disease: diagnosis based on elastography and hepatic vein waveform type.
    Koizumi Y; Hirooka M; Tanaka T; Watanabe T; Yoshida O; Tokumoto Y; Higaki T; Eguchi M; Abe M; Hiasa Y
    J Med Ultrason (2001); 2021 Apr; 48(2):235-244. PubMed ID: 33417157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for Fontan-associated hepatocellular carcinoma.
    Kogiso T; Sagawa T; Taniai M; Shimada E; Inai K; Shinohara T; Tokushige K
    PLoS One; 2022; 17(6):e0270230. PubMed ID: 35714161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rare Cause of a Left Abdominal Liver Mass.
    Ashhab AA; Singh D; Debes JD
    Gastroenterology; 2018 Jul; 155(1):e12-e13. PubMed ID: 29410119
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of Fontan-associated Liver Disease and Ethnic Disparities in Long-term Survivors of the Fontan Procedure: A Population-based Study.
    Emamaullee J; Martin S; Goldbeck C; Rocque B; Barbetta A; Kohli R; Starnes V
    Ann Surg; 2022 Sep; 276(3):482-490. PubMed ID: 35766375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Mid-Term Liver Disease After the Fontan Procedure.
    Oka N; Miyamoto T; Tomoyasu T; Hayashi H; Miyaji K
    Int Heart J; 2020 Sep; 61(5):979-983. PubMed ID: 32921662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma and focal nodular hyperplasia in patients with Fontan-associated liver disease: characterisation using dynamic gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MRI.
    Shiina Y; Inai K; Sakai R; Tokushige K; Nagao M
    Clin Radiol; 2023 Mar; 78(3):e197-e203. PubMed ID: 36481111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
    Kim MH; Nguyen A; Lo M; Kumar SR; Bucuvalas J; Glynn EF; Hoffman MA; Fischer R; Emamaullee J
    Transplantation; 2021 Jan; 105(1):18-22. PubMed ID: 32639398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.